Neal Shah, MD - Stony Brook Dermatology Associates

From routine appointments to emergency services, it's important to get the care you need-when you need it. But we understand you may be delaying your health needs over concerns about safety. At Mount Sinai, our doctors, nurses, and staff members are working continuously to ensure your safety so that you don't have to put your health on hold. Mount Sinai Queens is dedicated to building a caring and supportive relationship with you and your child. We are committed to caring for your infants, children, teenagers, and young adults up to age 21. We manage the full spectrum of children’s health, from allergies and asthma to sleep, breastfeeding, and behavioral difficulties. We also care for children with special needs. We believe in a holistic, patient-centered approach for children of all ages.

Dr. Dana Lukin specializes in the care of patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. He completed his medical and graduate training at the Mount Sinai School of Medicine, where he also completed training in Internal Medicine. After completing fellowship in gastroenterology and hepatology at New York Presbyterian Hospital-Columbia University Medical Center, he joined the faculty of Montefiore Medical Center where he co-founded the Einstein-Montefiore Program for Inflammatory Bowel Diseases. Dr. Lukin joined the Weill Cornell Faculty in July, 2018 as the Clinical Director of Translational Research for the Jill Roberts Center for Inflammatory Bowel Disease in order to provide the highest level of patient care, access to clinical trials, and to conduct high impact clinical and translational research studies in IBD. He is a founding member of IBD Research, Mentoring and Education in NY (IBD ReMEdY) and serves as the co-chair of the New York City Chapter Medical Advisory Committee for the Crohn’s & Colitis Foundation. Dr. Lukin is actively involved in collaborative research projects with the New York Crohn’s and Colitis Organization (NYCCO) and the Crohn’s & Colitis Foundation Clinical Research Alliance.